Ann: Phase I Clinical Trial Dosing Update No 3, page-38

  1. 1,435 Posts.
    lightbulb Created with Sketch. 190
    we have more news flow in the next 2 weeks and then a run way into more news with AGN and IND plus final pharmokinetics data. Company will become fundamentally stronger and proven for mechanism of action in humans. Rest takes care of itself. Looking for the licensing agreement CEO mentioned to take this to the promise land Kyriaco and that’s when we will be a billion dollar plus company
    Last edited by Bendunstan: 29/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.0¢
Change
0.010(3.03%)
Mkt cap ! $71.71M
Open High Low Value Volume
33.5¢ 34.5¢ 33.5¢ $174.4K 513.2K

Buyers (Bids)

No. Vol. Price($)
1 40000 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 97442 5
View Market Depth
Last trade - 15.59pm 28/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.